Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008
The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007
Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
TNF-a release suppression by pentoxifylline in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 105s Year: 2003
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006
Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2 Source: Eur Respir J 2003; 22: Suppl. 45, 8s Year: 2003
The production of IL-18, IL-12 and TNF-alpha by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis Source: Eur Respir J 2003; 22: Suppl. 45, 177s Year: 2003
Inhibition by roflumilast vs cilomilast of pulmonary leukocyte accumulation and TNFα release in a rat model of LPS-induced pulmonary neutrophilia Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol Source: Annual Congress 2009 - Airway cell biology Year: 2009
Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Endotoxin-induced IL-17 release by murine T-lymphocytes: interactions with airway macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001
Cytokine production of alveolar macrophages is decreased by OR2AT4 Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Prostaglandin-E2 mediated inhibition of TNFα release from human alveolar macrophages Source: Eur Respir J 2005; 26: Suppl. 49, 223s Year: 2005
IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM) Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005
Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002